Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn:
“Feeling incredibly grateful and touched!
One of my amazing patients surprised me today with zebra socks after reading my American Society of Clinical Oncology (ASCO) Educational book on,
‘Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras.’
Her thoughtful gesture truly made my day! It’s moments like these that remind me why I do what I do.”
